LISA DAVIS: Open Payments
NPI 1972809416 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 37 payments from 18 companies in 2025. Trend: 2023 $2,883 · 2024 $643 · 2025 $943
Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $269 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $102 |
| GlaxoSmithKline, LLC. | 3 | $80 |
| Grifols USA, LLC | 3 | $72 |
| Novartis Pharmaceuticals Corporation | 2 | $65 |
| Axsome Therapeutics, Inc. | 2 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| Novo Nordisk Inc | 2 | $39 |
| Azurity Pharmaceuticals, Inc. | 1 | $27 |
| AtriCure, Inc. | 1 | $26 |
Products named: BREZTRI, Xembify, FASENRA, CUVITRU, TRELEGY ELLIPTA, Sunosi, DUPIXENT, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
